Frontage Holdings Corporation is a contract research organization (CRO) providing integrated, scientifically-driven research, analytical and development services throughout the drug discovery and development process for pharmaceutical companies. Its offered services includes drug metabolism and pharmacokinetics, safety and toxicology services, chemistry, manufacturing and control (CMC), agrochemical services, and associated services supporting clinical studies, which includes early stage clinical services and biometrics services. The Company provides its services primarily through its wholly owned subsidiary in the United States, Frontage Laboratories, Inc. (Frontage Labs), and China, Frontage Laboratories (Shanghai) Co., Ltd.